A Cost Comparison of Infliximab Versus Intravenous Immunoglobulin for Refractory Kawasaki Disease Treatment

Address correspondence to Scarlett Carmen Johnson, MD, Division of General Pediatrics, Medical University of South Carolina, 135 Rutledge Ave, MSC 561, Charleston, SC 29425. E-mail: johnssca{at}musc.edu

Dr Brinton participated in study design, acquisition of data and model inputs, data analysis, and critical revision of the article; Mr Chew participated in MarketScan data analysis, acquisition of data, and revising the article for important intellectual content; Dr Andrews participated in study design and concept, sensitivity analyses, and critical review and revision of the manuscript; Dr Johnson participated in study design and concept, drafting the initial manuscript, data acquisition, sensitivity analyses, and revision of the manuscript; Dr Williams participated in study design and concept and critical revision of the manuscript for important intellectual content; Dr Simpson participated in study design and concept, data analysis and interpretation, and critical revision of the manuscript for important intellectual content; and all authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.